C12Y 101/03015
-2-hydroxy-acid oxidase
Official title: (S)-2-Hydroxy-acid oxidase (1.1.3.15)
C12Y101/03015 (-2-hydroxy-acid oxidase) appears on 17 US grants and 42 published applications in this corpus.
Search patents in C12Y- Granted patents
- 17
- Published applications
- 42
- Assignees
- 16
- Inventors
- 80
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 0 | 2 |
| 2019 | 4 | 5 |
| 2020 | 1 | 4 |
| 2021 | 4 | 5 |
| 2022 | 1 | 3 |
| 2023 | 2 | 9 |
| 2024 | 2 | 5 |
| 2025 | 0 | 5 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene6 Oct 2026US 12,752,019 B2Precision BioSciences, Inc.
- Method of producing thin enzyme-based sensing layers on planar sensors30 Apr 2024US 11,969,246 B2California Institute of Technology
- Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA16 Jan 2024US 11,873,493 B2Dicerna Pharmaceuticals, Inc.
- Gene editing systems comprising an RNA guide targeting hydroxyacid oxidase 1 (HAO1) and uses thereof21 Nov 2023US 11,821,012 B2Arbor Biotechnologies, Inc.
- Method of producing thin enzyme-based sensing layers on planar sensors4 Jul 2023US 11,690,544 B2California Institute of Technology
- Class ii, type v crispr systems30 Jul 2026US 2026/0218149 A1Metagenomi Therapeutics, Inc.
- Lactate oxidase variants and their uses for lactate detection4 Dec 2025US 2025/0368969 A1Assemzyme Co., Ltd.
- Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria2 Oct 2025US 2025/0304949 A1Precision BioSciences, Inc.
- Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression27 Feb 2025US 2025/0064936 A1Alnylam Pharmaceuticals, Inc.
- Lactate dehydrogenase a (ldha) irna compositions and methods of use thereof16 Jan 2025US 2025/0017953 A1Alnylam Pharmaceuticals, Inc.
Most cited
By later US patents
- Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA12US 9,701,966 B2Dicerna Pharmaceuticals, Inc. · 2017
- Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA6US 9,828,606 B2Dicerna Pharmaceuticals, Inc. · 2017
- Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA5US 10,487,330 B2Dicerna Pharmaceuticals, Inc. · 2019
- Method of producing thin enzyme-based sensing layers on planar sensors4US 11,026,610 B2California Institute of Technology · 2021
- Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA3US 10,435,692 B2Dicerna Pharmaceuticals, Inc. · 2019